Brian C. Stephenson, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 1,600 shares at $30.04 ($48K) on 2020-06-03, disclosed to the SEC on 2020-06-05.
Scheduled sale ($48k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FTH | BUY | 2026-06-24 | $406K | — | Filing → |
| BBIO | SELL | 2025-02-27 | $282K | — | Filing → |
| BBIO | SELL | 2025-02-19 | $300K | — | Filing → |